HIT Consultant October 29, 2025
What You Should Know:
– Indomo, a therapeutics company focused on developing at-home prescription dermatology treatments, today emerged from stealth with $25M in total funding led by leading investors including Atomic, Foresite Capital, and Polaris Partners.
– The company introduced the ClearPen™, an investigational at-home injectable therapy in development for the treatment of inflammatory acne lesions.
Solving the Inflammatory Acne Access Crisis
Acne is the most common skin condition in the U.S., affecting 50 million Americans annually. A significant portion of these sufferers, 20 million people, struggle specifically with inflammatory acne. Despite intralesional injections of triamcinolone acetonide (a corticosteroid) being a first-line treatment recommended by the American Academy of Dermatology, only about 1 million people regularly receive this...
Today's Sponsors
Today's Sponsor